Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
about
Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysisCritical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatmentMaternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty AcidsOmega-3 fatty acid and nutrient deficits in adverse neurodevelopment and childhood behaviorsNutritional supplements for the treatment of ADHDNon-Pharmacological Treatments for ADHD in YouthEffect of diet on brain metabolites and behavior in spontaneously hypertensive ratsDevelopmental effects of dietary n-3 fatty acids on activity and response to novelty.Reference values of whole-blood fatty acids by age and sex from European children aged 3-8 years.Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder.Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.The Relationship between Serum Vitamin D Level and Attention Deficit Hyperactivity Disorder.Conversion ratios of n-3 fatty acids between plasma and erythrocytes: a systematic review and meta-regression.Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial.Association between Blood Omega-3 Index and Cognition in Typically Developing Dutch AdolescentsFatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study.Marine Ο-3 polyunsaturated fatty acids induce sex-specific changes in reinforcer-controlled behaviour and neurotransmitter metabolism in a spontaneously hypertensive rat model of ADHD.Decreased Serum Cu/Zn SOD Associated with High Copper in Children with Attention Deficit Hyperactivity Disorder (ADHD)Omega-3 fatty acid supplementation provides an additional benefit to a low-dust diet in the management of horses with chronic lower airway inflammatory diseaseIron, Magnesium, Vitamin D, and Zinc Deficiencies in Children Presenting with Symptoms of Attention-Deficit/Hyperactivity Disorder.Role of docosahexaenoic acid in maternal and child mental health.Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials.Nutrient supplementation approaches in the treatment of ADHD.The use of omega-3 fatty acids in mental illness.Diet in the treatment of ADHD in children - a systematic review of the literature.Omega-3 and Zinc supplementation as complementary therapies in children with attention-deficit/hyperactivity disorder.Omega-6 to Omega-3 Fatty Acid Ratio in Patients with ADHD: A Meta-Analysis.The effect of alpha-linolenic acid supplementation on ADHD symptoms in children: a randomized controlled double-blind study.The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says.A non-targeted metabolite profiling pilot study suggests that tryptophan and lipid metabolisms are linked with ADHD-like behaviours in dogs.Omega-3 fatty acids are related to abnormal emotion processing in adolescent boys with attention deficit hyperactivity disorder.Do Omega-3/6 Fatty Acids Have a Therapeutic Role in Children and Young People with ADHD?Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trialsReduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.Altered serum mono- and polyunsaturated fatty acid levels in adults with ADHD.Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol).Scientific Opinion on the substantiation of a health claim related to eicosapentanoic acid (EPA) and “reduces the AA/EPA ratio in blood. A high AA/EPA level is a risk factor in the development of attention difficulties in children with ADHD-like s...Peripheral iron levels in children with attention-deficit hyperactivity disorder: a systematic review and meta-analysis.Polyunsaturated Fatty Acids Are Associated With Behavior But Not With Cognition in Children With and Without ADHD: An Italian study.Polyunsaturated fatty acids, cognition and literacy in children with ADHD with and without learning difficulties.
P2860
Q22252430-3748D2ED-9693-41CA-928C-895AAEE216ACQ26739640-03A51CC7-E442-4626-995C-92777E04E383Q26740518-4CD7C757-747B-4211-8D36-C2BAE52D1BACQ26822591-6988FEDC-2BE0-4082-9E89-9CAF8FAE6FECQ28247932-EEBBE778-F400-41C6-A89D-4B0229DB2FA6Q30377445-CF71E6E7-CF36-43B9-89D6-939B96E25D66Q33908059-FB793DE7-5386-490E-9357-EE532DBB7DFFQ34072669-6D9D666D-664E-4EE0-8E24-BE60B31794CFQ34196119-791F90F2-768A-4B7F-BBEF-F8B932710454Q35981290-B7893AE5-0708-4020-830B-7F68C1B6ED81Q36032585-C8BC13CF-EA10-4AA5-B690-925B49B52C82Q36350054-A26320A7-7A0F-40C5-B2FF-59612FA9CD4EQ36377135-AE21B289-8DD6-4C06-A8C1-5B0EB204B663Q36405752-5E328863-8EFF-432F-8391-A2F25375EF82Q36507414-A34352F2-8420-4F7C-9CA0-936B4B645E0EQ36510618-F488B1B2-ED83-4CF1-A9ED-80A63CA60BC5Q36614190-E2C46A92-2125-49DE-ADEA-8679F43ECD4BQ36866418-8657C970-5A46-40B5-9637-5A2EB138EC34Q36873659-8A0B3B7D-8B91-4410-91ED-08467B6F32B9Q37055850-E5DDF7D8-6183-40CA-AB04-A40853530464Q37155207-814342E1-AF70-403E-B9B3-E2669E1DEE5EQ37349962-0C684F72-74EF-4144-AC56-F322BE466700Q37432176-188A7447-FFC3-44A6-9695-A6AAA6FB1B60Q37937303-3FCDC1AF-096D-4BCF-8982-15896975B3AEQ38220703-DECD1814-7D40-404B-B4CD-DED4CD0BB36FQ38750927-139073B7-2FF8-4714-8242-39A925FE1BB0Q38856506-5ACEE92E-EC75-4541-8942-727FC38325BAQ39109080-A1B260C8-53B3-4883-B6CF-9FDA93EF0887Q39123700-C90015BE-225F-40D6-A5A3-22A1F0A0CE15Q41240585-CE90E0C7-EFE1-4136-8E67-F3EFE4E81520Q41439240-EC540673-650A-4863-8D4B-1C04C77443DDQ41689257-FECAA4AC-64B5-4F8E-9AAB-609FF3E7C08AQ41960525-6F335AA2-7A9B-4216-8E7D-972CF19BF6BCQ41987116-62A5D801-375B-4362-8A23-B59D4EAECBADQ46765528-9618CA60-9A43-475F-92BC-140E0887C416Q46895629-ACCCBDB6-0FAA-4F7A-8DDD-5B1128BEA17AQ47153155-DEEB847C-83B9-46D3-8B98-7ACDB9B8C742Q47555595-95ED9DB3-7EB2-4205-A751-6B369595730FQ47890341-D95643FE-1E98-47FD-B0C2-72A4D4DC0394Q50528223-3F034042-CBD0-4824-9F2C-AEF1B6728373
P2860
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
@ast
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
@en
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
@nl
type
label
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
@ast
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
@en
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
@nl
prefLabel
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
@ast
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
@en
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
@nl
P2093
P921
P1476
Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.
@en
P2093
Caryl J Antalis
John R Burgess
Karen Ericson
Laura J Stevens
Mary Campbell
Robert Pazdro
P304
P356
10.1016/J.PLEFA.2006.07.004
P577
2006-09-08T00:00:00Z